Overview Multihance at 3 Tesla (3T) in Brain Tumors Status: Completed Trial end date: 2008-03-01 Target enrollment: Participant gender: Summary Compare the efficacy of MultiHance and Magnevist Phase: Phase 4 Details Lead Sponsor: Bracco Diagnostics, Inc